Journal of Ophthalmic and Vision Research

Published date: Nov 13 2025

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: ‎Volume 20 - 2025

Pages: 1 - 6

DOI: 10.18502/jovr.v20.18397

Mona AmerMona.Amer@slucare.ssmhealth.comSSMHealth Medical Group, Department of Ophthalmology, School of Medicine, Saint Louis University, St. Louis, MO

Scott SonneScott.Sonne@slucare.ssmhealth.comSSMHealth Medical Group, Department of Ophthalmology, School of Medicine, Saint Louis University, St. Louis, MO

Niloofar Piriniloofar.piri@health.slu.eduSSMHealth Medical Group, Department of Ophthalmology, School of Medicine, Saint Louis University, St. Louis, MO

Hyperreflective choroidal foci (HCF) are a finding on optical coherence tomography that may serve as a biomarker in various retinal and choroidal pathologies. These discrete hyperreflective spots, identified in various layers of the choroid, have been linked to inflammatory, vascular, and degenerative conditions. This review examines the clinical significance, histopathological correlation, and implications of HCF in various diseases, including diabetic retinopathy, age-related macular degeneration, Stargardt disease, choroideremia, Vogt-Koyanagi-Harada disease (VKH), idiopathic posterior uveitis, retinitis pigmentosa, and central serous chorioretinopathy (CSR), as well as non-pathological states. Although further studies are required to validate the findings in each pathology described herein, HCF may be used as a background prognostic marker of disease progression and therapeutic response, albeit with caution.

Keywords: Age-related Macular Degeneration, Biomarkers, Diabetic Macular Edema, Hyperreflective Choroidal Foci, Optical Coherence Tomography, Stargardt Disease

1. Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C; Diabetic Retinopathy Research Group Vienna. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 2009;116:914–920.

2. Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, et al. Hyperreflective dots: A new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica 2013;229:32–37.

3. Piri N, Nesmith BL, Schaal S. Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging: Correlation with disease severity. JAMA Ophthalmol 2015;133:398–405.

4. Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N, et al. Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol 2012;153:710– 717, 717.e1.

5. Roy R, Saurabh K, Shah D, Chowdhury M, Goel S. Choroidal hyperreflective foci: A novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema. Asia Pac J Ophthalmol 2019;8:314–318.

6. Saurabh K, Roy R, Herekar S, Mistry S, Choudhari S. Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study. Indian J Ophthalmol 2021;69:3203–3206.

7. Cao D, Leong B, Messinger JD, Kar D, Ach T, Yannuzzi LA, et al. Hyperreflective foci, optical coherence tomography progression indicators in age-related macular degeneration, include transdifferentiated retinal pigment epithelium. Invest Ophthalmol Vis Sci 2021;62:34.

8. Curcio CA, Zanzottera EC, Ach T, Balaratnasingam C, Freund KB. Activated retinal pigment epithelium, an optical coherence tomography biomarker for progression in age-related macular degeneration. Invest Ophthalmol Vis Sci 2017;58:BIO211–26.

9. Borrelli E, Reibaldi M, Barresi C, Berni A, Introini U, Bandello F. Choroidal hyper-reflective foci in geographic atrophy. Invest Ophthalmol Vis Sci 2023;64:5.

10. Echols BS, Clark ME, Swain TA, Chen L, Kar D, Zhang Y, et al. Hyperreflective foci and specks are associated with delayed rod-mediated dark adaptation in nonneovascular age-related macular degeneration. Ophthalmol Retina 2020;4:1059–1068.

11. Battaglia Parodi M, Sacconi R, Romano F, Bandello F. Hyperreflective foci in Stargardt disease: 1-year follow-up. Graefes Arch Clin Exp Ophthalmol 2019;257:41–48.

12. Lee SY, Yoon CK, Park UC, Park KH, Lee EK. Choroidal hyperreflective foci as biomarkers of severity in Stargardt disease. Retina Phila Pa 2024;45.

13. Hanumunthadu D, Rasheed MA, Goud A, Gupta A, Vupparaboina KK, Chhablani J. Choroidal hyper-reflective foci and vascularity in retinal dystrophy. Indian J Ophthalmol 2020;68:130–133.

14. Romano F, Arrigo A, MacLaren RE, Charbel Issa P, Birtel J, Bandello F, et al. Hyperreflective foci as a pathogenetic biomarker in choroideremia. Retina 2020;40:1634–1640.

15. Hanumunthadu D, Matet A, Rasheed MA, Goud A, Vuppurabina KK, Chhablani J. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy. Indian J Ophthalmol 2019;67:1850– 1854.

16. Hwang BE, Kim JY, Kim RY, Kim M, Park YG, Park YH. Enface optical coherence tomography hyperreflective foci of choriocapillaris in central serous chorioretinopathy. Sci Rep 2023;13:7184.

17. Kim YH, Oh J. Hyperreflective foci in the choroid of normal eyes. Graefes Arch Clin Exp Ophthalmol 2022;260:759– 769.

18. Kim YH, Togloom A, Oh J. Correlation between hyperreflective foci in the choroid and choroidal discoloration in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2022;63:27.

19. Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011;31:502–509.

20. Agrawal R, Arora R, Keane PA, Agarwal A, Pavesio C. Morphometric features on enhanced depth imaging optical coherence tomography scans in idiopathic posterior uveitis or panuveitis. Int Ophthalmol 2018;38:993–1002.

21. Huang CH, Yang CH, Lai YJ, Hsiao CK, Hou YC, Yang CM, et al. Hyperreflective foci as important prognostic indicators of progression of retinitis pigmentosa. Retina 2022;42:388–395.

22. Parodi MB, Arrigo A, Romano F, Aragona E, Marchese A, Cicinelli MV, et al. Hyperreflective foci number correlates with choroidal neovascularization activity in angioid streaks. Invest Ophthalmol Vis Sci 2018;59:3314–3319.

23. Vujosevic S, Bini S, Midena G, Berton M, Pilotto E, Midena E. Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: An in vivo study using spectral domain OCT. J Diabetes Res 2013;2013:491835.

24. Framme C, Schweizer P, Imesch M, Wolf S, Wolf- Schnurrbusch U. Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci 2012;53:5814–5818.

25. Song MS, Kim YH, Oh J. Spatial distribution of hyperreflective choroidal foci in the macula of normal eyes. Transl Vis Sci Technol 2024;13:35.

26. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 2011;31:1603–1608.

27. Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26–34.

28. Kim YT, Kang SW, Bai KH. Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy. Eye 2011;25:1635–1640.

29. Tong J, Khou V, Trinh M, Alonso-Caneiro D, Zangerl B, Kalloniatis M. Derivation of human retinal cell densities using high-density, spatially localized optical coherence tomography data from the human retina. J Comp Neurol 2023;531:1108–1125.